v3.26.1
Schedule of Consummation of the Business Combination (Details)
Feb. 17, 2025
shares
Reverse Recapitalization  
PowerUp Class A common stock, outstanding prior to the Reverse Recapitalization 7,765,144
Less: Redemption of PowerUp Class A common stock (507,631)
Class A common stock of PowerUp 7,257,513
PowerUp Class B common stock, outstanding prior to the Reverse Recapitalization
Total Reverse Recapitalization Class A common stock, before giving effect to Reverse Splits (see Note 1. Description of Organization and Business) 7,257,513
Reverse Recapitalization Class A common stock, after giving effect to the Reverse Splits (see Note 1. Description of Organization and Business) 6,048
Issuance of shares related to working capital agreements 3,125
Aspire Biopharma, Inc. shares 29,167
Common Stock immediately after the Reverse Recapitalization, after giving effect to the Reverse Splits (see Note 1. Description of Organization and Business) 38,340